Morgan Stanley Morpho Sys Ag Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$17.36 - $19.34 $5.8 Million - $6.46 Million	-334,078 Reduced 99.89%	354 $6,000
Q2 2024 Aug 14, 2024	SELL	$17.36 - $19.34 $5.8 Million - $6.46 Million	-334,078 Reduced 99.89%	354 $6,000
Q1 2024 Oct 17, 2024	BUY	$8.6 - $18.18 $2.87 Million - $6.07 Million	334,078 Added 94372.32%	334,432 $6.07 Million
Q1 2024 Aug 16, 2024	BUY	$8.6 - $18.18 $562,336 - $1.19 Million	65,388 Added 24.3%	334,432 $6.07 Million
Q1 2024 May 15, 2024	BUY	$8.6 - $18.18 $562,336 - $1.19 Million	65,388 Added 24.3%	334,432 $6.07 Million
Q4 2023 Aug 16, 2024	BUY	$4.55 - $9.9 $1.22 Million - $2.66 Million	268,690 Added 75901.13%	269,044 $2.66 Million
Q4 2023 Feb 13, 2024	BUY	$4.55 - $9.9 $598,593 - $1.3 Million	131,559 Added 95.69%	269,044 $2.66 Million
Q3 2023 Nov 15, 2023	SELL	$6.72 - $8.6 $37,242 - $47,661	-5,542 Reduced 3.87%	137,485 $923,000
Q2 2023 Aug 14, 2023	SELL	$3.95 - $7.74 $9,878 - $19,357	-2,501 Reduced 1.72%	143,027 $1.07 Million
Q1 2023 May 15, 2023	SELL	$3.56 - $5.22 $12,193 - $17,878	-3,425 Reduced 2.3%	145,528 $576,000
Q4 2022 Feb 14, 2023	SELL	$3.21 - $5.74 $37,232 - $66,578	-11,599 Reduced 7.22%	148,953 $533,000
Q3 2022 Nov 14, 2022	SELL	$4.14 - $22.13 $62,513 - $334,163	-15,100 Reduced 8.6%	160,552 $808,000
Q2 2022 Oct 27, 2022	BUY	$4.51 - $7.39 $73,513 - $120,457	16,300 Added 10.23%	175,652 $849,000
Q2 2022 Aug 15, 2022	BUY	$4.51 - $7.39 $73,513 - $120,457	16,300 Added 10.23%	175,652 $849,000
Q1 2022 Oct 27, 2022	SELL	$5.87 - $9.73 $95,681 - $158,599	-16,300 Reduced 9.28%	159,352 $1.08 Million
Q1 2022 May 13, 2022	SELL	$5.87 - $9.73 $179,886 - $298,175	-30,645 Reduced 16.13%	159,352 $1.08 Million
Q4 2021 Feb 14, 2022	BUY	$9.08 - $12.45 $339,374 - $465,331	37,376 Added 24.49%	189,997 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$11.76 - $19.51 $1.79 Million - $2.98 Million	152,621 New	152,621 $1.79 Million

Others Institutions Holding MOR

# of Institutions

Shares Held

1.8M

Call Options Held

Put Options Held

14.7K

View Full List

About MorphoSys AG

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

More about MOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account